-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

330. Vascular Biology, Thrombosis, and Thrombotic Microangiopathies: Basic and Translational: Poster II

Symposia: Vascular Biology, Thrombosis, and Thrombotic Microangiopathies: Basic and Translational Program: Oral and Poster Abstracts
Type: Poster
Sunday, December 8, 2024: 6:00 PM-8:00 PM
Halls G-H (San Diego Convention Center)

Romy De Laat-Kremers, PhD1*, Shengshi Huang2,3*, Hugo Ten Cate, MD4,5, Marisa Ninivaggi2*, Bas De Laat2,6 and Katrien M.J. Devreese, PhD, MD7,8*

1Department of Data Analysis and Artificial Intelligence, Synapse Research Institute, Washington, MD
2Department of Functional Coagulation, Synapse Research Institute, Maastricht, Netherlands
3Department of Biochemistry, Maastricht University, Maastricht, Netherlands
4Departments of Internal medicine and Biochemistry, Maastricht University Medical Center, Maastricht, Netherlands
5Cardiovascular Research Institute Maastricht (CARIM) and department of Internal medicine, Maastricht University Medical Center, Maastricht, Netherlands
6Department of Data Analysis and Artificial Intelligence, Synapse Research Institute, Maastricht, Netherlands
7Department of Diagnostic Sciences, Ghent University, Ghent, Belgium
8Coagulation Laboratory, Ghent University Hospital, Ghent, Belgium

Bryan Bouwens, MSc1*, Elke Magdeleyns1*, Stijn Agten1*, Stella Thomassen1*, Dennis Suylen1*, Tilman M. Hackeng, PhD1 and Rory R. Koenen2*

1Cardiovascular Research Institute Maastricht (CARIM), Dpt. of Biochemistry, Maastricht university(UM), Maastricht University Medical center (MUMC+), Maastricht, Netherlands
2CARIM - Biochemistry, Maastricht University, Maastricht, Netherlands

Sarah E Sartain, MD1, Paula Jacobi2*, Virginie Qian3*, Mrinal Ranjan, MPH4*, Saleh Bhar, M.D.5*, Ang Li, MD, MS4 and Andrew Yee, PhD.6*

1Department of Pediatrics, Section of Hematology-Oncology, Baylor College of Medicine/Texas Children's Hospital, Houston, TX
2Department of Pediatrics, Section of Hematology, Baylor College of Medicine, Texas Children's Hospital, Houston, TX
3Southern Illinois University, Carbondale, IL
4Baylor College of Medicine, Houston, TX
5Department of Pediatrics, Divisions of Hematology, Oncology, and Critical Care Medicine, Cell Therapy and Bone Marrow Transplantation, Baylor College of Medicine/Texas Children's Hospital, Houston, TX
6Department of Pediatrics, Baylor College of Medicine, Houston, TX

Sooho S Myoung1*, Samuel Francis, MD2, Jonah Chen3*, Grace M Lee4, Lubica Rauova, MD, PhD5*, Mortimer Poncz, MD5*, Douglas B. Cines, MD6, Maragatha Kuchibhatla4*, Sanjay Khandelwal, PhD7* and Gow Arepally3

1Medical Scientist Training Program, The Ohio State University, Columbus, OH
2Emergency Medicine, Duke University School of Medicine, Durham, NC
3Division of Hematology, Duke University Medical Center, Durham, NC
4Duke University Medical Center, Durham, NC
5Division of Hematology, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA
6Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA
7Duke University School of Medicine, Durham, NC

Amrita Sarkar, PhD1, Conroy O Field, MS2,3, Keith R. McCrae, MD4, Thomas L. Ortel, MD, PhD5, Gow Arepally, MD6, Roxanne Cofiell7*, Sung-Kwon Kim7*, Lubica Rauova, MD, PhD1,8 and Mortimer Poncz, MD3,8*

1Division of Hematology, Children's Hospital of Philadelphia, Philadelphia, PA
2Perelman School of Medicine Pharmacology Graduate Group, University of Pennsylvania, Philadelphia, PA
3Division of Hematology, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA
4Department of Cardiovascular and Metabolic Sciences, Lerner Research Institute, The Cleveland Clinic Foundation, Cleveland, OH
5Division of Hematology, Duke University School of Medicine, Durham, NC
6Duke University School of Medicine, Durham, NC
7Alexion, AstraZeneca Rare Diseases, New Haven, CT
8Department of Pediatrics, University of Pennsylvania, Philadelphia, PA

Sarah E. Tashbook1*, Tomasz W. Kaminski, PharmD2*, Prithu Sundd, PhD2,3 and Tomasz Brzoska, PhD1,4

1Pittsburgh Heart, Lung and Blood Vascular Medicine Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA
2Thrombosis and Hemostasis Program, VERSITI Blood Research Institute and Blood Center of Wisconsin, Milwaukee, WI
3Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI
4Division of Hematology/Oncology, University of Pittsburgh School of Medicine, Pittsburgh, PA

Kim-Anh Nguyen-Peyre1*, Marie-Sophie Meuleman, MD2*, Gwellaouen Bodivit3*, Christian Kassasseya, MD4,5*, Xavier Decrouy, PhD6*, Benoit Vingert, PhD7,8*, Laura Bencheikh, PhD5*, John Lambris, PhD9,10*, France Pirenne, MD, PhD11,12, Lubka T. Roumenina, PhD13,14* and Pablo Bartolucci, MD, PhD15,16*

1INSERM U955 IMRB Team Pirenne, French Blood Establishment, Créteil Mondor, Créteil, FL, France
2INSERM, Centre de Recherche des Cordeliers, Paris France, Paris, FRA
3INSERM U955, IMRB, team Pirenne, French Blood Establishment, Créteil France, CRETEIL, FRA
4Henri Mondor Hospital - Emergency Department, Creteil, FRA
5INSERM U955, IMRB, team Pirenne, Créteil France, Créteil, France
6INSERM U955, IMRB, Imaging platform, Créteil France, Créteil, -- None selected --, France
7INSERM-U955, EFS, Institut Mondor, Université Paris-Est Créteil, Team 2 Transfusion et maladies du globule rouge, Laboratoire d´Excellence GR-Ex, Créteil, France
8Etablissement Français du Sang, Hôpital Henri Mondor, Creteil, FRA
9Department of Pathology & Laboratory Medicine, Philadelphia, PA
10University of Pennsylvania School, Philadelphia, PA
11Transfusion et maladies du globule rouge - Equipe Pirenne, Institut Mondor de Recherche Biomedicale (IMRB), Creteil, France
12Etablissement Francais Du Sang - Université Paris-Est Créteil Hospital, Creteil, France
13Sorbonne Université, Paris, France
14Centre de Recherche des Cordeliers, INSERM, Paris, France
15Hematology Department, Sickle Cell Referral Center, Department of Internal Medicine, Henri-Mondor University Hospital- UPEC, AP-HP, Créteil, France
16Université Paris-Est Créteil, INSERM U955, IMRB, Laboratory of excellence LABEX GRex, Créteil, France

James V Michael, PhD1, Sanjay Khandelwal, PhD2*, Antonios Tawk, MD1*, Sophia Lazar, PhD1*, Gow Arepally3 and Steven E McKenzie, MD, PhD1

1The Cardeza Foundation for Hematologic Research, Thomas Jefferson University, Philadelphia, PA
2Duke University School of Medicine, Durham, NC
3Division of Hematology, Duke University Medical Center, Durham, NC

Bruna Cardoso Jacintho1*, Guilherme Leonardi, PhD2*, Bruna Mazetto3,4*, José Oliveira, PhD5*, Fabiola Zakia Monica2*, Erich Vinicius De Paula, MD, PhD6 and Fernanda A. Orsi, MD, PhD7*

1School of Medical Sciences, University of Campinas (UNICAMP), Campinas, AC, Brazil
2Department of Translational Medicine (Pharmacology), University of Campinas (UNICAMP),, Campinas, Brazil
3University of Campinas (UNICAMP), Campinas, BRA
4Division of Rheumatology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI
5University of Campinas (UNICAMP), Campinas, LA, Brazil
6Hematology and Hemotherapy Center, University of Campinas, Campinas, Brazil
7Department of Pathology, School of Medical Sciences, Unicamp, Campinas, Brazil

Amrita Sarkar, PhD1, Santosh K Yadav, PhD1*, Conroy O Field, MS2,3, Kandace Gollomp, MD3,4*, Keith R. McCrae, MD5, Thomas L. Ortel, MD, PhD6, Yves Gruel7*, Jérôme Rollin7*, Gowthami M Arepally, MD8*, Lubica Rauova, MD, PhD3,4*, Douglas B. Cines, MD9 and Mortimer Poncz, MD3,4*

1Division of Hematology, Children's Hospital of Philadelphia, Philadelphia, PA
2Perelman School of Medicine Pharmacology Graduate Group, University of Pennsylvania, Philadelphia, PA
3Division of Hematology, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA
4Department of Pediatrics, University of Pennsylvania, Philadelphia, PA
5Department of Cardiovascular and Metabolic Sciences, Lerner Research Institute, The Cleveland Clinic Foundation, Cleveland, OH
6Division of Hematology, Duke University School of Medicine, Durham, NC
7Department of Hemostasis, Université de Tours, Tours, France
8Division of Hematology, Duke University Medical Center, Durham
9Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA

Jing Yuan Tan, MBBS1, Wan Hui Wong1*, May Anne Cheong, MBBS, FRCPath (UK)1*, Cecilia Cheng Lai Ngan, MBBS, FRCPA2*, Wenshan Liu1*, Choo Kheng Tan1*, Hong Kheng Neo1*, Lai Heng Lee, MBBS, FRCP(Edin)1*, Heng Joo Ng, MBBS, FRCPath(UK)1* and Chuen Wen Tan, MBBCh BAO, FRCPath (UK)1*

1Department of Haematology, Singapore General Hospital, Singapore, Singapore
2Department of Microbiology, Singapore General Hospital, Singapore, Singapore

Shruti Chaturvedi, MBBS1, Yan Wang2*, Moh-Lim Ong2*, Arpita Nag3*, Rui Song4*, Lynn Huynh, MPH4*, Jordan A. Burdeau4*, Mei Sheng Duh4* and Ramy Magdy Hanna5*

1Division of Hematology, Department of Medicine, Johns Hopkins Hospital, BALTIMORE, MD
2Alexion, AstraZeneca Rare Disease, Boston, MA
3Alexion, AstraZeneca Rare Disease, Boston, MA, USA, Boston, MA
4Analysis Group, Inc., Boston, MA
5University of California, Irvine, CA

*signifies non-member of ASH